| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | RDEA119 | FIMM | pan-cancer | AAC | -0.41 | 0.01 |
| mRNA | Vandetanib | FIMM | pan-cancer | AAC | -0.34 | 0.04 |
| mRNA | ATRA | FIMM | pan-cancer | AAC | -0.29 | 0.05 |
| mRNA | 17-AAG | FIMM | pan-cancer | AAC | -0.28 | 0.1 |
| mRNA | AZD6244 | FIMM | pan-cancer | AAC | -0.27 | 0.1 |
| mRNA | Bortezomib | FIMM | pan-cancer | AAC | -0.26 | 0.07 |
| mRNA | Methotrexate | FIMM | pan-cancer | AAC | -0.23 | 0.07 |
| mRNA | CEP-701 | FIMM | pan-cancer | AAC | -0.2 | 0.1 |
| mRNA | Crizotinib | FIMM | pan-cancer | AAC | -0.18 | 0.3 |
| mRNA | paclitaxel | FIMM | pan-cancer | AAC | -0.17 | 0.2 |